BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19618600)

  • 1. Influences of signal quality for determination of PICSO timing.
    Mina S; Meindl M; Mohl W
    Wien Klin Wochenschr; 2007; 119(11-12 Suppl 1):31-2. PubMed ID: 19618600
    [No Abstract]   [Full Text] [Related]  

  • 2. PICSO in progress: lactate, oxygen, eNOS, iNOS, MMP and TIMP in the PICSO treated myocardium--a preview.
    Lechner J; Grünbichler H; Schrutka I; Waldthaler A; Franz C; Mohl W
    Wien Klin Wochenschr; 2007; 119(11-12 Suppl 1):29. PubMed ID: 19618598
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of pressure-controlled intermittent coronary sinus occlusion (PICSO) on myocardial ischaemia and reperfusion in a closed-chest porcine model.
    Khattab AA; Stieger S; Kamat PJ; Vandenberghe S; Bongoni A; Stone GW; Seiler C; Meier B; Hess OM; Rieben R
    EuroIntervention; 2013 Jul; 9(3):398-406. PubMed ID: 23872654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary hemodynamic effects of pressure-controlled intermittent coronary sinus occlusion (PICSO): results from the First-In-Man Prepare PICSO Study.
    Van de Hoef TP; Nolte F; Delewi R; Henriques JP; Spaan JA; Tijssen JG; Siebes M; Wykrzykowska JJ; Stone GW; Piek JJ
    J Interv Cardiol; 2012 Dec; 25(6):549-56. PubMed ID: 22994798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do long term effects after PICSO endorse the potential of cardiac regeneration after acute myocardial infarction?
    Kasahara H; Komamura K; Glogar D; Kodama K; Hirayama A; Mohl W
    Wien Klin Wochenschr; 2007; 119(11-12 Suppl 1):23-6. PubMed ID: 19618595
    [No Abstract]   [Full Text] [Related]  

  • 6. Soluble plasma factors derived from ischemic, PICSO-treated, porcine hearts are not responsible for HO-1 and VEGF mRNA expression in endothelial cells.
    Schuler M; Winter B; Eichmair E; Nigisch A; Mohl W; Weigel G
    Wien Klin Wochenschr; 2007; 119(11-12 Suppl 1):30. PubMed ID: 19618599
    [No Abstract]   [Full Text] [Related]  

  • 7. Protection of the ischemic heart: the role of pre- and postconditioning.
    Philipp S; Kordish I; Sack S; Erbel R
    Wien Klin Wochenschr; 2007; 119(11-12 Suppl 1):26-8. PubMed ID: 19618596
    [No Abstract]   [Full Text] [Related]  

  • 8. Can we do more for the STEMI patient than restore coronary blood flow?
    Erlinge D
    Cardiology; 2010; 116(2):101-2. PubMed ID: 20588017
    [No Abstract]   [Full Text] [Related]  

  • 9. Cold cardioplegia for acute infarction a viable adjunct to reperfusion therapy?
    Wijns W; Heyndrickx GR
    J Am Coll Cardiol; 2007 Jan; 49(2):261-2. PubMed ID: 17222739
    [No Abstract]   [Full Text] [Related]  

  • 10. Microvascular dysfunction and benefit of postconditioning.
    Goyal BK
    Catheter Cardiovasc Interv; 2008 Aug; 72(2):221. PubMed ID: 18655153
    [No Abstract]   [Full Text] [Related]  

  • 11. Myocardial protection via the coronary sinus.
    Mohl W; Komamura K; Kasahara H; Heinze G; Glogar D; Hirayama A; Kodama K
    Circ J; 2008 Apr; 72(4):526-33. PubMed ID: 18362420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiological options for acute protection of the reperfused myocardium].
    Breuckmann F; Heusch G; Erbel R; Philipp S
    Dtsch Med Wochenschr; 2008 Mar; 133(12):591-4. PubMed ID: 18335391
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of systemic BP on coronary blood flow and infarct size during reperfusion therapy for acute myocardial infarction: refinements beyond the "plumbing".
    Madias JE
    Chest; 2004 Apr; 125(4):1179-81. PubMed ID: 15078717
    [No Abstract]   [Full Text] [Related]  

  • 14. [Myocardial retroperfusion: the idea, the experimentation, the clinical perspectives].
    Volpini M; Oh BH
    Cardiologia; 1990 Nov; 35(11):883-92. PubMed ID: 2099242
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute molecular effects of pressure-controlled intermittent coronary sinus occlusion in patients with advanced heart failure.
    Mohl W; Spitzer E; Mader RM; Wagh V; Nguemo F; Milasinovic D; Jusić A; Khazen C; Szodorai E; Birkenberg B; Lubec G; Hescheler J; Serruys PW
    ESC Heart Fail; 2018 Dec; 5(6):1176-1183. PubMed ID: 30230713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "no-reflow" phenomenon: basic science and clinical correlates.
    Reffelmann T; Kloner RA
    Heart; 2002 Feb; 87(2):162-8. PubMed ID: 11796561
    [No Abstract]   [Full Text] [Related]  

  • 17. Lethal reperfusion injury in acute myocardial infarction: facts and unresolved issues.
    Garcia-Dorado D; Ruiz-Meana M; Piper HM
    Cardiovasc Res; 2009 Jul; 83(2):165-8. PubMed ID: 19502282
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ultrasound-induced myocardial preconditioning: analysis of its effectiveness and mechanisms].
    Galagudza MM; Shmonin AA; Mishchenko KA; Vlasov TD; Petrishchev NN
    Biofizika; 2008; 53(4):691-6. PubMed ID: 18819289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of pre and post conditioning to prevent cardiac ischemic sequelae.
    Meijer RC; Kappetein AP; Serruys PW; Bogers JJ
    Wien Klin Wochenschr; 2007; 119(11-12 Suppl 1):21-3. PubMed ID: 19618594
    [No Abstract]   [Full Text] [Related]  

  • 20. Pressure and flow across severe stenoses: does the intra-aortic balloon pump do its job?
    Kern MJ
    Am Heart J; 2007 Oct; 154(4):615-6. PubMed ID: 17892980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.